Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > insider buys 1 000 000 Shares at 0.062!

<< Previous

Bullboard Posts

Next >>

Post by backflipson May 17, 2018 11:44pm

171 Views

Post# 28050458

insider buys 1 000 000 Shares at 0.062!

Amended Filing

As of 11:59pm ET May 16th, 2018

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Apr 8/18	Apr 6/18	Frost, Phillip	Indirect Ownership	Common Shares	10 - Acquisition in the public market	1,000,000	$0.062
May 2/18	Feb 27/18	Janzen, Doug	Direct Ownership	Options	52 - Expiration of options	-65,000
Apr 22/18	Feb 27/18	Marko, Alexei	Direct Ownership	Options	52 - Expiration of options	-40,000	$2.49
Apr 22/18	Feb 27/18	Geyer, Paul	Direct Ownership	Options	52 - Expiration of options	-80,000	$2.49
Apr 22/18	Feb 27/18	Lane, Randy	Direct Ownership	Options	52 - Expiration of options	-16,000	$2.49
Apr 22/18	Feb 27/18	Hsiao, Jane	Direct Ownership	Options	52 - Expiration of options	-65,000	$2.49
Apr 22/18	Feb 27/18	William, O'Neill	Direct Ownership	Options	52 - Expiration of options	-65,000	$2.49
Apr 22/18	Feb 27/18	Rubin, Steven Daniel	Direct Ownership	Options	52 - Expiration of options	-75,000	$2.49
Apr 22/18	Feb 27/18	Clark, Christopher John	Direct Ownership	Options	52 - Expiration of options	-32,000	$2.49
Feb 15/18	Feb 15/18	Frost, Phillip	Indirect Ownership	Common Shares	10 - Disposition in the public market	-300,000